本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Oscar Health, Inc.

14.25
+0.37002.67%
盘后14.380.1288+0.90%16:36 EST
成交量:1,045.73万
成交额:1.51亿
市值:37.72亿
市盈率:-13.94
高:14.74
开:14.15
低:14.01
收:13.88
52周最高:23.80
52周最低:11.20
股本:2.65亿
流通股本:2.17亿
量比:0.49
换手率:4.82%
股息:- -
股息率:- -
每股收益(TTM):-1.0222
每股收益(LYR):0.1058
净资产收益率:-22.24%
总资产收益率:-2.57%
市净率:3.68
市盈率(LYR):134.69

数据加载中...

2025/11/12

关联方拟减持公告

Form 144 | OSCAR HEALTH 高管 Mario T. Schlosser 拟减持105300股,总价约158万美元
2025/11/12

关联方拟减持公告

Form 144 | OSCAR HEALTH, INC. 高管 Mario T Schlosser 拟减持286,182股,总价约436.95万美元
2025/11/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/09/22

关联方拟减持公告

Form 144 | OSCAR HEALTH, INC. 高管 Mario T Schlosser 拟减持395,000股,总价约728万美元
2025/09/18

重要事件披露

Form 8-K - Current report
2025/09/16

重要事件披露

Form 8-K - Current report
2025/09/15

重要事件披露

Form 8-K - Current report
2025/09/03

重要事件披露

Form 8-K - Current report
2025/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/06

重要事件披露

Form 8-K - Current report
2025/07/22

重要事件披露

Form 8-K - Current report
2025/06/20

关联方拟减持公告

Form 144 | OSCAR HEALTH INC高管 Ranmali Bopitiya 拟减持30000股,总价约56.3万美元
2025/06/06

重要事件披露

Form 8-K - Current report
2025/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/05/07

重要事件披露

Form 8-K - Current report